The Cionic Neural Sleeve is a first-of-its-kind healthcare product at
the intersection of design, data, and the human body. The FDA-cleared,
AI-powered bionic clothing senses, analyzes, and augments muscle
movement, improving mobility with every step. Beautifully designed and
app-controlled, the garment enables freer, more independent movement.
Nearly 80% of people who need a pacemaker require a dual chamber option
to pace both chambers of the heart. As the world’s first dual chamber
leadless pacemaker system, AVEIR DR expands access to leadless pacing.
With its i2i (implant-to-implant) technology, AVEIR DR is an engineering
marvel, providing synchronized pacing based on clinical needs.
The Movement And Compressions (MAC) System is an FDA class II wearable
medical device and the only mechanical compression device on the market
with a 510(k) clearance for cordless/tubeless DVT prevention with the
added benefit of monitoring patient orientation and movement.
Moderna’s BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster
(mRNA-1273.22) targets the original strain of SARS-CoV-2 and BA.4/BA.5
Omicron subvariants. It was developed per U.S. FDA guidance to protect
against COVID-19 variants for fall and winter 2022. mRNA-1273.222 is
authorized in the U.S., UK, EU and other countries.
This innovation uses coordinated supramolecular complex (CSC) technology
to develop an eye drop formulation for treating wet age-related macular
degeneration (AMD). CSC for posterior eye delivery addresses the
shortcomings of current treatments, providing a non-invasive and
self-administrable alternative for patients.
BioDrone™ is a next-generation drug delivery platform that relies on
cell-derived vesicles obtained from MDimune’s proprietary extrusion
technology that converts virtually any human cells into nanovesicles.
BioDrone™ is safe and highly effective in the targeted delivery of
various drugs, thereby reducing side effects and maximizing efficacy.
Nose It All™️is a medical-grade oral device that stops nosebleeds at the
arterial source, up to 3x faster than any traditional method. Inserted
under the top lip, pressure is directed upwards toward the anterior
artery using the patented bite tab, stopping nosebleeds in as little as
3 minutes, hands-free, without tissues, sponges, or chemicals.
eXciteOSA is the first FDA-authorized, non-invasive daytime therapy that
targets a root cause of OSA and snoring by improving the endurance of
the tongue muscle. It’s clinically proven to reduce OSA and snoring in 6
weeks. The therapy combines a digital platform to foster patient
adherence, a device, and the expertise of a Sleep Advocate team.
Mammography Quality Evaluation (MQE) uses 11 criteria of mammography
quality that enhance radiographers’ skills and mammography process.
Radiographers can adjust operations referring to MQE’s quality warnings
and visual information. MQE helps hospitals to acquire quality
mammograms and minimizes the chance of patient recall for retaking
mammograms.
The Recursion OS harnesses multiple breakthrough technologies, including
machine learning, to create, organize and study vast amounts of
biological data to build Maps of Biology that can predict trillions of
relationships across biology and chemistry to discover novel insights.